Skip to main navigation Skip to main content
info(at)avldigital.remove-this.de
Deutsch English
Narrow Search
Search narrowed by
Last searches

Results for *

Displaying results 1 to 2 of 2.

  1. "Napsterizing" pharmaceuticals
    access, innovation, and consumer welfare
    Author: Hughes, James W.; Moore, Michael J.; Snyder, Edward A.
    Published: 2002
    Publisher:  NBER, Cambridge, Mass.

    Location:
    Universitätsbibliothek Braunschweig
    Signature:
    2838-2247
    Inter-library loan:
    Unlimited inter-library loan, copies and loan

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    W 1 (9229)
    Inter-library loan:
    Unlimited inter-library loan, copies and loan
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Print
    Series: NBER working paper series ; 9229
    Subjects: Arzneimittel; Generika; Patent; Konsumentenrente; Markenartikel; Innovation; Imitationsstrategie; USA; Cost-Benefit Analysis; Drugs; Drugs, Generic; Drugs, Generic; Generic drugs; Models, Economic; Patents as Topic; Pharmaceutical Preparations; Pharmaceutical Preparations
    Scope: 54 S, graph. Darst
    Notes:

    Internetausg.: papers.nber.org/papers/w9229.pdf - lizenzpflichtig
  2. Generic script share and the price of brand-name drugs
    the role of consumer choice
    Author: Rizzo, John A.; Zeckhauser, Richard
    Published: 2005
    Publisher:  National Bureau of Economic Research, Cambridge, Mass.

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    W 1 (11431)
    Inter-library loan:
    Unlimited inter-library loan, copies and loan
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Print
    Series: NBER working paper series ; 11431
    Subjects: Arzneimittel; Generika; Preis; Preiswettbewerb; USA; Drug Industry; Drugs; Drugs, Generic; Economic Competition; Generic drugs; Prescription Fees
    Scope: 42 S
    Notes:

    Literaturverz. S. 32

    Internetausg.: papers.nber.org/papers/w11431.pdf - lizenzpflichtig